Press release Biocartis Group NV

Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings) - Seite 2

• Chain of controlled undertakings through which the holding is effectively held :
  This disclosure is made on behalf of Invesco Ltd. and relates to shares beneficially owned by various mutual and pension funds managed by Invesco Ltd. and its subsidiary companies, whereby Invesco Ltd. has discretion as to the acquisition and disposal of the shares and as to the exercise of the voting rights associated with the shares. Invesco Ltd. is not a controlled entity. Invesco Ltd. is the parent company controlling the voting rights for Invesco Advisers, Inc.
  

• Additional information:
  The acquisition of the shares in the (company), by Invesco (on behalf of funds managed by affiliates of the group management companies) to Invesco Ltd, is part of the normal course of its portfolio management company activity, conducted without intent to implement a particular strategy for the company, or to exercise, as such, a specific influence on the management of the latter. The company, Invesco (on behalf of funds managed by affiliates of the group management companies) is not acting in concert with a third party and does not intend to take control of the company.
  

3.         Miscellaneous

This press release can be consulted on the website of BIOCARTIS GROUP NV via this link Press releases | Biocartis Group NV.

--- END ---

More information:

Investor Relations Biocartis Group NV
e-mail        [e-mail]

Biocartis and Idylla are registered trademarks in Europe, the United States and other countries. The Biocartis and Idylla trademark and logo are used trademarks owned by Biocartis. Please refer to the product labeling for applicable intended uses for each individual Biocartis product.
This press release is not for distribution, directly or indirectly, in any jurisdiction where to do so would be unlawful. Any persons reading this press release should inform themselves of and observe any such restrictions. Biocartis takes no responsibility for any violation of any such restrictions by any person. This press release does not constitute an offer or invitation for the sale or purchase of securities in any jurisdiction. No securities of Biocartis may be offered or sold in the United States of America absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended.